Form D — Allay Therapeutics, Inc.
0001766366-25-000001 · filed 2025-02-10
Offering
- Industry
- Biotechnology
- Exemptions
- 06b
- Total offering
- $59,999,995
- Total sold
- $44,999,997
- Minimum investment
- $1
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- Allay Therapeutics, Inc.
- CIK
- 1766366
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- —
- Address
- 2720 ZANKER ROAD
SAN JOSE, CA 95134 - Phone
- 650-514-6284
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Michael A. Carusi · DirectorSan Jose, CA Find on LinkedIn ↗
-
Mark Deem · DirectorSan Jose, CA Find on LinkedIn ↗
-
Nicole Vitullo · DirectorSan Jose, CA Find on LinkedIn ↗
-
J.C. Lopez · DirectorSan Jose, CA Find on LinkedIn ↗
-
Tiffany Le · DirectorSan Jose, CA Find on LinkedIn ↗
-
Leighton Read · DirectorSan Jose, CA Find on LinkedIn ↗
-
Adam Gridley · Executive OfficerSan Jose, CA Find on LinkedIn ↗
-
Paul McCreadie · DirectorSan Jose, CA Find on LinkedIn ↗
-
Anselm Tan · DirectorSan Jose, CA Find on LinkedIn ↗
-
Kristen Howells · Executive OfficerSan Jose, CA Find on LinkedIn ↗
View original on SEC EDGAR.